MX173433B - Composicion acuosa de ibuprofen y procedimiento para su preparacion - Google Patents
Composicion acuosa de ibuprofen y procedimiento para su preparacionInfo
- Publication number
- MX173433B MX173433B MX020055A MX2005590A MX173433B MX 173433 B MX173433 B MX 173433B MX 020055 A MX020055 A MX 020055A MX 2005590 A MX2005590 A MX 2005590A MX 173433 B MX173433 B MX 173433B
- Authority
- MX
- Mexico
- Prior art keywords
- volume
- percent
- composition
- weight percent
- ibuprofen
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001680 ibuprofen Drugs 0.000 title abstract 3
- 239000000796 flavoring agent Substances 0.000 abstract 4
- 235000019634 flavors Nutrition 0.000 abstract 4
- 239000004615 ingredient Substances 0.000 abstract 3
- 230000000873 masking effect Effects 0.000 abstract 3
- 239000003381 stabilizer Substances 0.000 abstract 3
- 239000000725 suspension Substances 0.000 abstract 3
- 230000003139 buffering effect Effects 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invenciòn se refiere a procedimiento para la preparación de una composición de ibuprofen acuosa, de sabor neutro, apropiada para administración oral, que comprende aproximadamente 0,8 por ciento hasta aproximadamente 4 por ciento en peso de ibuprofen por volumen de la composición total en una combinación estabilizadora de suspensión primaria de ingredientes y una combinación primaria enmascaradora de sabor de ingredientes, caracterizado porque la combinación estabilizadora de suspensión de ingredientes comprende aproximadamente un0.1 por ciento hasta aproximadamente 2 por ciento en peso de combinación estabilizadora de suspensión por volumen de la composición total, comprendiendo la combinación enmascaradora de sabor aproximadamente un 20 por ciento hasta aproximadamente un 70 por ciento en peso de combinación enmascaradora de sabor por volumen de la composición total, conteniendo tambien la composición uno o más ácidos tamponadores farmaceuticamente aceptables y una cantidad suficiente para ajustar el pH entre aproximadamente 1,5 y hasta aproximadamente 3,5 y para proporcionar una capacidad tamponadora dentro de los límites de 0,03 a 0,05 entre el pH inicial y pH que es un 1,0 unidad de pH más elevado que el pH inicial, y agua en una cantidad suficiente para 100 por ciento en volumen de la composición.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/329,624 US4975465A (en) | 1989-03-28 | 1989-03-28 | Orally administrable ibuprofen compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
MX20055A MX20055A (es) | 1993-10-01 |
MX173433B true MX173433B (es) | 1994-03-03 |
Family
ID=23286273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX020055A MX173433B (es) | 1989-03-28 | 1990-03-27 | Composicion acuosa de ibuprofen y procedimiento para su preparacion |
Country Status (15)
Country | Link |
---|---|
US (1) | US4975465A (es) |
EP (1) | EP0390369B1 (es) |
JP (1) | JP2847134B2 (es) |
KR (1) | KR0143899B1 (es) |
AR (1) | AR245366A1 (es) |
AT (1) | ATE100313T1 (es) |
AU (1) | AU629622B2 (es) |
CA (1) | CA1336819C (es) |
DE (1) | DE69006068T2 (es) |
DK (1) | DK0390369T3 (es) |
ES (1) | ES2048428T3 (es) |
HK (1) | HK68194A (es) |
IE (1) | IE64024B1 (es) |
MX (1) | MX173433B (es) |
NZ (1) | NZ233102A (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994041A (en) * | 1985-04-06 | 1999-11-30 | Eastman Kodak Company | Process for buffering concentrated aqueous slurries |
NZ234143A (en) * | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
AU2584092A (en) * | 1992-09-03 | 1994-03-29 | Affinity Biotech, Inc. | Taste-masking pharmaceutical compositions and methods for making the same |
CA2121435C (en) * | 1993-04-16 | 2002-01-22 | Sheila M. Ratnaraj | Aqueous pharmaceutical suspension and process for preparation thereof |
DE4327147C2 (de) * | 1993-08-12 | 1996-12-19 | Klinge Co Chem Pharm Fab | Arzneimittelzusammensetzung, welche neben dem Wirkstoff ein Gemisch aus Gelatine unterschiedlicher Löslichkeit enthält |
FR2713931B1 (fr) * | 1993-12-20 | 1996-04-05 | Laurence Paris | Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation. |
US5609998A (en) * | 1994-12-29 | 1997-03-11 | Eastman Kodak Company | Process for dispersing concentrated aqueous slurries |
TW442287B (en) * | 1995-06-13 | 2001-06-23 | American Home Produits Corp | Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac) |
CA2253260A1 (en) * | 1996-05-02 | 1997-11-13 | Taisho Pharmaceutical Co., Ltd. | Suspension of sparingly water-soluble acidic drug |
GB9625589D0 (en) | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
DK1082109T3 (da) | 1998-04-29 | 2004-08-09 | Sumitomo Pharma | Oral formulering omfattende biguanid og en organisk syre |
GB0001315D0 (en) * | 2000-01-20 | 2000-03-08 | Novartis Ag | Organic compounds |
US20030039687A1 (en) * | 2001-08-01 | 2003-02-27 | Michael Corbo | Taste masking composition |
US20040132823A1 (en) * | 2001-11-02 | 2004-07-08 | Leo Pavliv | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
ES2197781B1 (es) * | 2001-12-04 | 2005-02-16 | Farmalider, S.A. | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. |
JP4619658B2 (ja) * | 2002-03-12 | 2011-01-26 | 富山化学工業株式会社 | 快い味の経口懸濁液および方法 |
US7300670B2 (en) | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
CN101862292A (zh) * | 2002-06-17 | 2010-10-20 | 塔罗制药美国公司 | 布洛芬混悬剂 |
KR100509432B1 (ko) * | 2002-12-13 | 2005-08-22 | 주식회사 동구제약 | S(+)-이부프로펜을 함유한 시럽제 조성물 및 그의 제조방법 |
FR2850275B1 (fr) | 2003-01-24 | 2005-04-08 | Scherer Technologies Inc R P | Capsules molles a macher contenant une substance active a gout masque |
ATE534371T1 (de) * | 2003-02-06 | 2011-12-15 | Gebro Pharma Gmbh | Pharmazeutische zubereitungen und verfahren zu deren herstellung |
US20040186180A1 (en) * | 2003-03-21 | 2004-09-23 | Gelotte Cathy K. | Non-steroidal anti-inflammatory drug dosing regimen |
CA2542755A1 (en) * | 2003-10-17 | 2005-04-28 | Medrx Co., Ltd. | Biguanide drug-containing jelly preparation |
GB2407497A (en) * | 2003-10-30 | 2005-05-04 | John Anthony Walters | Method and formulation for the rapid and stable taste-masking of insoluble pharmaceutically active compounds using a surfactant and a hydrocolloid |
US20050095300A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
US20050095299A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
US20050266031A1 (en) * | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
PL2486942T3 (pl) * | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
US8394415B2 (en) | 2006-11-21 | 2013-03-12 | Mcneil-Ppc, Inc | Modified release analgesic suspensions |
US9833510B2 (en) * | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
US8362083B2 (en) * | 2008-01-15 | 2013-01-29 | C.B. Fleet Company Inc. | Taste-masked docusate compositions |
GB201006218D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
AU2013235266B2 (en) | 2012-03-20 | 2017-10-19 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4145440A (en) * | 1977-08-18 | 1979-03-20 | The Upjohn Company | Liquid suspension of an aluminum salt of ibuprofen |
US4361580A (en) * | 1980-06-20 | 1982-11-30 | The Upjohn Manufacturing Company | Aluminum ibuprofen pharmaceutical suspensions |
US4631580A (en) * | 1984-11-09 | 1986-12-23 | John Taube | Video-stereoscopic-image-producing system |
GB8609566D0 (en) * | 1986-04-18 | 1986-05-21 | Boots Co Plc | Analgesic method |
US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
-
1989
- 1989-03-28 US US07/329,624 patent/US4975465A/en not_active Expired - Lifetime
- 1989-07-12 CA CA000605461A patent/CA1336819C/en not_active Expired - Lifetime
-
1990
- 1990-03-15 ES ES90302750T patent/ES2048428T3/es not_active Expired - Lifetime
- 1990-03-15 DE DE90302750T patent/DE69006068T2/de not_active Expired - Lifetime
- 1990-03-15 EP EP90302750A patent/EP0390369B1/en not_active Expired - Lifetime
- 1990-03-15 DK DK90302750.6T patent/DK0390369T3/da active
- 1990-03-15 AT AT90302750T patent/ATE100313T1/de not_active IP Right Cessation
- 1990-03-27 MX MX020055A patent/MX173433B/es unknown
- 1990-03-27 AU AU52269/90A patent/AU629622B2/en not_active Expired
- 1990-03-27 AR AR90316469A patent/AR245366A1/es active
- 1990-03-27 NZ NZ233102A patent/NZ233102A/xx unknown
- 1990-03-27 JP JP2078586A patent/JP2847134B2/ja not_active Expired - Lifetime
- 1990-03-27 KR KR1019900004086A patent/KR0143899B1/ko not_active IP Right Cessation
- 1990-03-27 IE IE111990A patent/IE64024B1/en not_active IP Right Cessation
-
1994
- 1994-07-14 HK HK68194A patent/HK68194A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0390369A3 (en) | 1991-05-15 |
ES2048428T3 (es) | 1994-03-16 |
DK0390369T3 (da) | 1994-04-11 |
AU629622B2 (en) | 1992-10-08 |
CA1336819C (en) | 1995-08-29 |
AU5226990A (en) | 1990-10-04 |
AR245366A1 (es) | 1994-01-31 |
NZ233102A (en) | 1991-08-27 |
JPH02286615A (ja) | 1990-11-26 |
IE901119L (en) | 1990-09-28 |
IE64024B1 (en) | 1995-06-28 |
EP0390369A2 (en) | 1990-10-03 |
US4975465A (en) | 1990-12-04 |
HK68194A (en) | 1994-07-22 |
DE69006068D1 (de) | 1994-03-03 |
KR0143899B1 (ko) | 1998-07-15 |
EP0390369B1 (en) | 1994-01-19 |
JP2847134B2 (ja) | 1999-01-13 |
MX20055A (es) | 1993-10-01 |
KR900013952A (ko) | 1990-10-22 |
ATE100313T1 (de) | 1994-02-15 |
DE69006068T2 (de) | 1994-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX173433B (es) | Composicion acuosa de ibuprofen y procedimiento para su preparacion | |
NL300027I1 (nl) | Omeprazole-derivaten. | |
ES2031467T3 (es) | Formulaciones acuosas de esteroides apropiadas para administracion por via nasal. | |
IT1178235B (it) | Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione | |
AR002976A1 (es) | Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas | |
BR0317149A (pt) | Métodos para uso de uma composição para bebidas | |
ES2093735T3 (es) | Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica. | |
ES2038632T3 (es) | Una preparacion para curar heridas y su procedimiento de elaboracion. | |
NO20022264L (no) | Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav | |
EE03039B1 (et) | Meetod hüdrateeritud tsefalosporiini kuiva pulbrilise segu valmistamiseks, sellel meetodil valmistatud segu ja farmatseutilised kompositsioonid | |
HU9400430D0 (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
ES2028917T3 (es) | Un procedimiento para preparar una composicion farmaceutica inyectable estable. | |
ES8707111A1 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
BR9306800A (pt) | Composição tópica oftalmológica e processo para a preparação de uma composição oftalmológica para uso tópico | |
IL91813A0 (en) | Pharmaceutical compositions containing stable oxapenem-3-carboxylic acids and their preparation | |
IL80976A0 (en) | 4-thienyl-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
PE20001038A1 (es) | Uso de cetiricina para la prevencion del inicio del asma | |
SE8303012L (sv) | Farmaceutisk komposition |